Avid Bioservices, Inc. reported earnings results for the full year ended April 30, 2024. For the full year, the company reported sales was USD 139.91 million compared to USD 149.27 million a year ago. Sales was USD 139.91 million compared to USD 149.27 million a year ago.

Net loss was USD 140.75 million compared to net income of USD 0.259 million a year ago. Net loss was USD 140.75 million compared to net income of USD 0.259 million a year ago. Basic loss per share from continuing operations was USD 2.23.

Diluted loss per share from continuing operations was USD 2.23.